Table 1

Baseline characteristics of the study population
Variables Number (%)
Gender
Male 31 (27.2)
Female 83 (72.8)
Total 114 (100)
Age group (years)
15 – 24 2 (1.7)
25 – 34 23 (20.2)
35+ 89 (78.1)
Total 114 (100)
CD4 count
<350 42 (36.8)
350 – 499 32 (28.1)
500+ 40 (35.1)
Total 114 (100)
Duration of ART*(years)
<2 38 (34.2)
2 – 4 30 (27.0)
5+ 43 (38.7)
Total 111 (100)
NRTI** regimen
AZT-based 75 (65.8)
D4T-based 4 (3.5)
TDF-based 35 (30.7)
Total 114 (100)
NNRTI** regimen
EFV-based 54 (47.4)
NVP-based 60 (52.6)
Total 114 (100)
Smoking
No 106 (94.6)
Yes 6 (5.4)
Total 112 (100)
Alcohol intake
No 63 (56.2)
Yes 49 (43.5)
Total 112 (100)
Heart condition
No 104 (93.7)
Yes 7 (6.3)
Total 111 (100)
Metabolic condition
No 102 (91.9)
Yes 9 (8.1)
Total 111 (100)
Special diet
No 101 (91.0)
Yes 10 (9.0)
Total 111 (100)
ART interruption
No 107 (95.5)
Yes 5 (4.5)
Total 112 (100)

*ART = antiretroviral therapy, **NRTI = nucleotide reverse transcriptase inhibitors, *** NNRTI = non-nucleotide reverse transcriptase inhibitor, AZT = zidovudine, 3TC = lamivudine, TDF = tenofovir, D4T = stavudine, EFV = efavirenz, NVP = nevirapine.

Bekolo et al.

Bekolo et al. BMC Public Health 2014 14:236   doi:10.1186/1471-2458-14-236

Open Data